Daiwa Securities Group Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6
-14.3%
2170.0%0.00%
Q2 2023$7
-12.5%
2170.0%0.00%
Q1 2023$80.0%2170.0%0.00%
Q4 2022$8
-99.9%
217
+19.2%
0.00%
Q3 2022$6,000
+20.0%
1820.0%0.00%
Q2 2022$5,000
-16.7%
1820.0%0.00%
Q1 2022$6,000
+20.0%
1820.0%0.00%
Q4 2021$5,0000.0%1820.0%0.00%
Q3 2021$5,000
+66.7%
182
+83.8%
0.00%
Q2 2021$3,0000.0%990.0%0.00%
Q1 2021$3,000
+50.0%
990.0%0.00%
Q4 2020$2,000
-66.7%
99
-66.6%
0.00%
Q3 2020$6,000
+20.0%
2960.0%0.00%
Q2 2020$5,0000.0%2960.0%0.00%
Q1 2020$5,000
-28.6%
2960.0%0.00%
Q4 2019$7,000
-22.2%
296
-10.8%
0.00%
Q3 2019$9,000
-18.2%
3320.0%0.00%
Q2 2019$11,000
-8.3%
3320.0%0.00%
Q1 2019$12,000
+33.3%
332
+17.3%
0.00%
Q4 2018$9,000
-35.7%
2830.0%0.00%
Q3 2018$14,000
-17.6%
2830.0%0.00%
Q2 2018$17,000
-99.5%
283
-99.6%
0.00%
-100.0%
Q1 2018$3,159,00068,9830.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders